We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMI
13276
DELISTED
Chembio diagnostics, Inc.
CEMI
$9K ﹤0.01%
10,642
-186,133
-95% -$174K
FTFT icon
13277
PUT
Future FinTech Group
FTFT
$1.47M
$8K ﹤0.01%
14
-16
-53% -$10.8K
TCRT icon
13278
PUT
Alaunos Therapeutics
TCRT
$4.86M
$8K ﹤0.01%
87
-605
-87% -$77.7K
PIXY
13279
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
ORTX
13280
CALL
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$8K ﹤0.01%
+1,090
New +$10.7K
DLCAW
13281
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$8K ﹤0.01%
39,933
-85
-0.2% -$32
DXF
13282
Eason Technology Ltd
DXF
$1.55M
$7K ﹤0.01%
8
-16
-67% -$15.4K
RKTO
13283
Rocket One Inc
RKTO
$18.9M
$7K ﹤0.01%
+435
New +$7.28K
TWAV
13284
PUT
TaoWeave Inc
TWAV
$4.42M
$7K ﹤0.01%
17
-10
-37% -$4.46K
STAB
13285
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$7K ﹤0.01%
+20,368
New +$21.8K
LJAQW
13286
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$7K ﹤0.01%
24,296
CPTK.WS
13287
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$7K ﹤0.01%
26,199
+1,017
+4% +$434
GSQD.WS
13288
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$7K ﹤0.01%
17,785
-463
-3% -$240
AMPE
13289
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7K ﹤0.01%
47
-41
-47% -$5.99K
ETACW
13290
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$7K ﹤0.01%
41,340
-1,347
-3% -$399
CXAIW icon
13291
CXApp Inc Warrant
CXAIW
$955K
$6K ﹤0.01%
39,738
-49,969
-56% -$14.3K
MDAIW icon
13292
Spectral AI Warrants
MDAIW
$5.45M
$6K ﹤0.01%
32,789
PETZ icon
13293
PUT
TDH Holdings
PETZ
$16.4M
$6K ﹤0.01%
+650
New +$9.42K
TALKW
13294
DELISTED
Talkspace Inc Warrant
TALKW
$6K ﹤0.01%
23,880
-29,816
-56% -$6.36K
DMK
13295
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
151
-96
-39% -$4.12K
AGILW
13296
DELISTED
AgileThought Inc Warrant
AGILW
$6K ﹤0.01%
12,597
-147
-1% -$68
FOXWW
13297
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$6K ﹤0.01%
83,718
-100
-0.1% -$18
PKBOW
13298
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$6K ﹤0.01%
16,084
+795
+5% +$340
KIIIW
13299
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$6K ﹤0.01%
33,141
-120,116
-78% -$39.7K
ZSAN
13300
DELISTED
Zosano Pharma Corporation
ZSAN
$6K ﹤0.01%
+814
New +$8.96K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.